Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Proposes "Trial Sizes" Of Prescriptions To Curb Waste Of Unused Drugs In Part D

This article was originally published in The Pink Sheet Daily

Executive Summary

Under a plan outlined in a draft Medicare Part D "call letter," patients receiving a new prescription for a drug previously unused by them would be able to receive an initial trial size supply of no more than seven to 14 days.

You may also be interested in...



Part D Trial-Size Prescriptions Will Be Voluntary For Plans In 2011

CMS will not require Medicare Part D plan sponsors to allow beneficiaries to obtain seven- to 14-day trial supplies of medicines that are new to enrollees, the agency says in its final "call letter" to contractors for the 2011 benefit year

Part D Trial-Size Prescriptions Will Be Voluntary For Plans In 2011

CMS will not require Medicare Part D plan sponsors to allow beneficiaries to obtain seven- to 14-day trial supplies of medicines that are new to enrollees, the agency says in its final "call letter" to contractors for the 2011 benefit year

Part D "Trial Size" Scripts Proposed, With Drug Tolerance And Waste In Mind

A proposal to offer "trial size" prescriptions for Medicare Part D beneficiaries trying new medications to treat chronic conditions already has garnered some mixed reactions

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS070263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel